Attività
Numero di dipendenti: 341
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23/02/17 |
Andrew Saik
DFI | Director of Finance/CFO | 54 | 21/06/21 |
M. Berrey
CTO | Chief Tech/Sci/R&D Officer | 57 | 09/06/21 |
Jose Truzman
SEC | Corporate Secretary | - | - |
Rocco Venezia
AUD | Comptroller/Controller/Auditor | 48 | 01/01/16 |
General Counsel | 55 | 11/01/21 | |
Corporate Officer/Principal | 60 | 01/01/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23/02/17 |
Director/Board Member | 55 | 08/11 | |
Stefano Pasi
BRD | Director/Board Member | - | 08/11 |
Michele Cera
BRD | Director/Board Member | - | 08/11 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 41 825 966 | 40 940 614 ( 97,88 %) | 0 | 97,88 % |
Coordinate società
Intercept Pharmaceuticals, Inc.
305 Madison Avenue
07960, Morristown
+646 747 1000
http://www.interceptpharma.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+7,52% | 113 Mrd | |
+11,38% | 106 Mrd | |
-12,64% | 22,22 Mrd | |
+0,44% | 22,27 Mrd | |
-4,18% | 19,43 Mrd | |
-37,85% | 17,87 Mrd | |
-8,58% | 17,24 Mrd | |
+37,41% | 12,52 Mrd | |
-23,95% | 8,34 Mrd |